Sona Nanotech is developing Targeted Hyperthermia™, a photothermal cancer therapy that uses therapeutic heat to treat solid cancer tumors. The heat is delivered to tumors by infrared light stimulation of Sona’s patented and uniquely biocompatible gold nanorods in the tumor which convert the light energy to heat. This therapeutic heat (42-48°C) has been shown in preclinical studies to both shrink tumors and stimulate the immune system, turning immunogenic ‘cold’ tumors into ‘hot’ ones, enabling immunotherapies to work better. Targeted Hyperthermia promises to be a precise, safe, effective, minimally invasive, competitive in cost, and valuable adjunct to drug therapy and other cancer treatments.
